Drosha, Ribonuclease Type III (DROSHA) (Middle Region) Peptide
DROSHA
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all DROSHA products
- DROSHA (Drosha, Ribonuclease Type III (DROSHA))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- YPLPKAPSER RSPERLKHYD DHRHRDHSHG RGERHRSLDR RERGRSPDRR
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- DROSHA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DROSHA (Drosha, Ribonuclease Type III (DROSHA))
- Background
-
Members of the ribonuclease III superfamily of double-stranded (ds) RNA-specific endoribonucleases participate in diverse RNA maturation and decay pathways in eukaryotic and prokaryotic cells. The RNase III Drosha is the core nuclease that executes the initiation step of microRNA (miRNA) processing in the nucleus.
Alias Symbols: RN3, ETOHI2, RNASEN, RANSE3L, RNASE3L, HSA242976
Protein Size: 1306 - Gene ID
- 29102
- NCBI Accession
- NM_001100412, NP_001093882
-
You are here:
